Cryo Cell International (CCEL) Gross Profit (2010 - 2026)

Cryo Cell International has disclosed Gross Profit across 17 years of filings, most recently posting $6.0 million for Q1 2026.

• In Q1 2026, Gross Profit rose 0.71% year-over-year to $6.0 million; the TTM figure through Feb 2026 stood at $24.2 million (changed 0.41% YoY), while the FY2025 annual figure was $24.2 million, up 0.63% from the prior year.
• Gross Profit declined to $6.0 million in Q1 2026, from $6.1 million in the prior quarter.
• Over the last five years, Gross Profit for CCEL reached as high as $6.4 million in Q4 2024 and fell as low as $5.2 million in Q1 2022.
• The 5-year median for Gross Profit is $5.9 million (2023), against an average of $5.8 million.
• Annual changes were most pronounced in 2022 — Gross Profit grew 12.07% — and 2025, when it fell 4.36%.
• A 5-year view of Gross Profit shows it stood at $5.6 million in 2022, then climbed by 4.05% to $5.9 million in 2023, then climbed by 9.13% to $6.4 million in 2024, then dropped by 4.36% to $6.1 million in 2025, then declined by 1.35% to $6.0 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $6.0 million, $6.1 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.